Professor Angela Webster FAHMS is a clinical epidemiologist at the Sydney School of Public Health, University of Sydney, nephrologist and transplant physician at Westmead Hospital and director of Evidence Integration at the NHMRC Clinical Trials Centre, University of Sydney.
Biography
Webster is a clinical academic with a focus on transplant medicine, kidney disease and epidemiology.
Webster's research themes include multimorbidity and the interaction of chronic diseases, specifically kidney disease, cancer, cardiovascular disease, diabetes, infection, and mental illness, addressed through evidence integration. Her researched is focused on improving clinical outcomes and using data to improve clinical decision making, by communicating and evaluating risk. She has a particular interest in health inequalities and mitigating factors that create disadvantage in health and healthcare settings.
Select publications
Year | Title | Journal | Ref |
---|---|---|---|
2017 | Chronic Kidney Disease | The Lancet | [1] |
2021 | Sex differences in mortality among binational cohort of people with chronic kidney disease: population based data linkage study | BMJ | [2] |
2016 | Cognition in chronic kidney disease: a systematic review and meta-analysis | Biomed Central Medicine. | [3] |
2015 | Readability of Written Materials for CKD Patients: A Systematic Review. | American Journal of Kidney Diseases | [4] |
2021 | Supporting patients to be involved in decisions about their health and care: Development of a best practice health literacy App for Australian adults living with Chronic Kidney Disease. | Health Promotion Journal of Australia | [5] |
2019 | Residual risk of infection with blood-borne viruses in potential organ donors at increased risk of infection: systematic review and meta-analysis. | Medical Journal of Australia | [6] |
2014 | Survival after cutaneous melanoma in kidney transplant recipients: a population-based matched cohort study | American Journal of Transplantation | [7] |
2021 | The landscape of COVID-19 trials in Australia | Medical Journal of Australia. | [8] |
2022 | Searching clinical trials registers: guide for systematic reviewers. | BMJ | [9] |
2013 | Interventions for smoking cessation and reduction in individuals with schizophrenia | Cochrane Database of Systematic Reviews | [10] |
Awards
Year | Award | Organisation | Ref |
---|---|---|---|
2023 | Elected as Fellow of the Australian Academy of Health and Medical Sciences | Australian Academy of Health and Medical Sciences | [11] |
2020 | TJ Neale Award for Outstanding Contribution to Nephrological Science | Australian and New Zealand Society of Nephrology | |
2019 | Josette Eris Memorial Award for emerging female leaders | Transplantation Society of Australia and New Zealand | |
2015 | Ian McKenzie Prize for outstanding contribution in transplantation | Transplantation Society of Australia and New Zealand |
References
- ↑ Webster, Angela C; Nagler, Evi V; Morton, Rachael L; Masson, Philip (March 2017). "Chronic Kidney Disease". The Lancet. 389 (10075): 1238–1252. doi:10.1016/S0140-6736(16)32064-5. PMID 27887750. S2CID 4925820.
- ↑ De La Mata, Nicole L; Rosales, Brenda; MacLeod, Grace; Kelly, Patrick J; Masson, Philip; Morton, Rachael L; Wyburn, Kate; Webster, Angela C (2021-11-16). "Sex differences in mortality among binational cohort of people with chronic kidney disease: population based data linkage study". BMJ. 375: e068247. doi:10.1136/BMJ-2021-068247. ISSN 1756-1833. PMC 8593820. PMID 34785509.
- ↑ Berger, Israel; Wu, Sunny; Masson, Philip; Kelly, Patrick J.; Duthie, Fiona A.; Whiteley, William; Parker, Daniel; Gillespie, David; Webster, Angela C. (December 2016). "Cognition in chronic kidney disease: a systematic review and meta-analysis". BMC Medicine. 14 (1): 206. doi:10.1186/s12916-016-0745-9. ISSN 1741-7015. PMC 5155375. PMID 27964726.
- ↑ Morony, Suzanne; Flynn, Michaela; McCaffery, Kirsten J.; Jansen, Jesse; Webster, Angela C. (June 2015). "Readability of Written Materials for CKD Patients: A Systematic Review". American Journal of Kidney Diseases. 65 (6): 842–850. doi:10.1053/j.ajkd.2014.11.025. hdl:2123/22350. PMID 25661679.
- ↑ Muscat, Danielle Marie; Lambert, Kelly; Shepherd, Heather; McCaffery, Kirsten J.; Zwi, Stephanie; Liu, Na; Sud, Kamal; Saunders, John; O’Lone, Emma; Kim, Jinman; Robbins, Aphra; Webster, Angela C. (February 2021). Smith, James (ed.). "Supporting patients to be involved in decisions about their health and care: Development of a best practice health literacy App for Australian adults living with Chronic Kidney Disease". Health Promotion Journal of Australia. 32 (S1): 115–127. doi:10.1002/hpja.416. ISSN 1036-1073. PMID 32888215.
- ↑ Waller, Karen MJ; De La Mata, Nicole L; Kelly, Patrick J; Ramachandran, Vidiya; Rawlinson, William D; Wyburn, Kate R; Webster, Angela C (November 2019). "Residual risk of infection with blood-borne viruses in potential organ donors at increased risk of infection: systematic review and meta-analysis". Medical Journal of Australia. 211 (9): 414–420. doi:10.5694/mja2.50315. ISSN 0025-729X. PMID 31489635. S2CID 201846138.
- ↑ Vajdic, C.M.; Chong, A.H.; Kelly, P.J.; Meagher, N.S.; Van Leeuwen, M.T.; Grulich, A.E.; Webster, A.C. (June 2014). "Survival After Cutaneous Melanoma in Kidney Transplant Recipients: A Population-Based Matched Cohort Study". American Journal of Transplantation. 14 (6): 1368–1375. doi:10.1111/ajt.12716. PMID 24730453. S2CID 7791631.
- ↑ Seidler, Anna Lene; Aberoumand, Mason; Williams, Jonathan G; Tan, Aidan; Hunter, Kylie E; Webster, Angela (2021-07-19). "The landscape of COVID-19 trials in Australia". Medical Journal of Australia. 215 (2): 58–61.e1. doi:10.5694/mja2.51148. ISSN 0025-729X. PMC 8447014. PMID 34275134.
- ↑ Hunter, Kylie E; Webster, Angela C; Page, Matthew J; Willson, Melina; McDonald, Steve; Berber, Slavica; Skeers, Peta; Tan-Koay, Ava G; Parkhill, Anne; Seidler, Anna Lene (2022-04-26). "Searching clinical trials registers: guide for systematic reviewers". BMJ. 377: e068791. doi:10.1136/bmj-2021-068791. ISSN 1756-1833. PMID 35473822.
- ↑ Tsoi, Daniel T; Porwal, Mamta; Webster, Angela C (2013-02-28). Cochrane Tobacco Addiction Group (ed.). "Interventions for smoking cessation and reduction in individuals with schizophrenia". Cochrane Database of Systematic Reviews. 2013 (2): CD007253. doi:10.1002/14651858.CD007253.pub3. PMC 6486303. PMID 23450574.
- ↑ Tamowicz, Celeste (2023-10-12). "Professor Angela Webster". Australian Academy of Health and Medical Sciences. Retrieved 2023-11-24.